2023
Long-Term Patient Outcomes After Femoropopliteal Peripheral Vascular Intervention in Patients With Intermittent Claudication
Altin S, Parise H, Hess C, Rosenthal N, Creager M, Aronow H, Curtis J. Long-Term Patient Outcomes After Femoropopliteal Peripheral Vascular Intervention in Patients With Intermittent Claudication. JACC Cardiovascular Interventions 2023, 16: 1668-1678. PMID: 37438035, DOI: 10.1016/j.jcin.2023.05.001.Peer-Reviewed Original ResearchMeSH KeywordsFemoral ArteryHumansIntermittent ClaudicationLower ExtremityPopliteal ArteryTreatment OutcomeConceptsPeripheral vascular interventionsIndex limb amputationAmputation rateIntermittent claudicationMajor amputationRevascularization ratesVascular interventionsCox proportional hazards regressionLong-term patient outcomesMajor amputation rateProportional hazards regressionKaplan-Meier estimatesFurther risk factorsLimb amputation rateClinical trial dataIndex limbIC patientsSecondary outcomesPrimary outcomeHazards regressionRisk factorsPatient outcomesLimb amputationHealthcare databasesPatients
2022
Sex-Based Differences in Periprocedural Complications Following Lower Extremity Peripheral Vascular Intervention
Altin S, Gitto M, Secemsky E, Rao S, Hess C. Sex-Based Differences in Periprocedural Complications Following Lower Extremity Peripheral Vascular Intervention. Circulation Cardiovascular Interventions 2022, 15: e011768. PMID: 35938403, DOI: 10.1161/circinterventions.121.011768.Peer-Reviewed Original ResearchMeSH KeywordsFemaleHematomaHumansLower ExtremityMaleOdds RatioPeripheral Arterial DiseaseRetrospective StudiesRisk FactorsTreatment OutcomeConceptsLower extremity peripheral vascular interventionsPeripheral vascular interventionsSymptomatic peripheral artery diseasePeripheral artery diseasePeriprocedural complicationsArtery diseaseHigh riskHospital mortalityKnee amputationFemale sexVascular interventionsVascular Quality Initiative registryAccess site bleedingAccess site complicationsPercutaneous coronary interventionCoronary artery diseaseSex-based outcomesMultivariate logistic regressionWarrants further investigationSex-based differencesBaseline patientSite bleedingCoronary interventionSite complicationsContemporary cohortStatins and statin intensity in peripheral artery disease.
Sagris M, Katsaros I, Giannopoulos S, Rosenberg RD, Altin SE, Rallidis L, Mena-Hurtado C, Armstrong EJ, Kokkinidis DG. Statins and statin intensity in peripheral artery disease. Vasa 2022, 51: 198-211. PMID: 35673949, DOI: 10.1024/0301-1526/a001012.Peer-Reviewed Original ResearchConceptsMajor adverse cardiovascular eventsPeripheral artery diseaseLow-intensity statinsLoss of patencyStatin useStatin doseIntensity statinsArtery diseaseFirst-line lipid-lowering therapyAdverse cardiovascular eventsAmputation-free survivalHigher statin doseLipid-lowering therapyMyocardial infarction rateRisk of amputationImpact of statinsStatin intensityCardiovascular eventsPAD patientsCardiovascular deathCardiovascular mortalityCause mortalityInfarction rateIschemia patientsStatin treatment